Oncopeptides AB (publ) (STO:ONCO)
Sweden
· Delayed Price · Currency is SEK 1.460
+0.020 (1.39%)
Mar 31, 2025, 2:58 PM CET
Oncopeptides AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -284.61 | -249.11 | -337.95 | -1,430 | -1,595 | Upgrade
|
| Depreciation & Amortization | - | 11.04 | 16.84 | 14.57 | 14.12 | Upgrade
|
| Other Amortization | - | - | 0.32 | 0.42 | 0.28 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 16.59 | - | Upgrade
|
| Stock-Based Compensation | - | 11.5 | 14.81 | 14.54 | 38.92 | Upgrade
|
| Other Operating Activities | 26.72 | 4.14 | -3.84 | -94.11 | 102.59 | Upgrade
|
| Change in Accounts Receivable | - | -16.02 | 53.17 | 24.66 | -7.75 | Upgrade
|
| Change in Inventory | - | -2.42 | -1.46 | -0.32 | -0.43 | Upgrade
|
| Change in Accounts Payable | - | -13.19 | -22.89 | -104.91 | 55.15 | Upgrade
|
| Change in Other Net Operating Assets | -2.68 | -25.42 | -139.52 | 42.49 | 95.3 | Upgrade
|
| Operating Cash Flow | -260.57 | -279.49 | -420.51 | -1,516 | -1,297 | Upgrade
|
| Capital Expenditures | - | -0.12 | -2.51 | -0.34 | -17.18 | Upgrade
|
| Investment in Securities | - | -0 | - | - | -3.13 | Upgrade
|
| Other Investing Activities | 0.5 | 0 | - | - | 0.18 | Upgrade
|
| Investing Cash Flow | 0.5 | -0.12 | -2.51 | -0.34 | -20.13 | Upgrade
|
| Long-Term Debt Repaid | - | -9.14 | -15.54 | -15.41 | -14.26 | Upgrade
|
| Net Debt Issued (Repaid) | - | -9.14 | -15.54 | -15.41 | -14.26 | Upgrade
|
| Issuance of Common Stock | 313.48 | 116.02 | 436.02 | 1,116 | 1,423 | Upgrade
|
| Other Financing Activities | -49.67 | - | -28.07 | -67.05 | -85.23 | Upgrade
|
| Financing Cash Flow | 263.81 | 106.89 | 392.4 | 1,034 | 1,323 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.39 | 1.61 | 12.94 | 4.63 | -92.76 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | - | - | -0 | - | Upgrade
|
| Net Cash Flow | 5.13 | -171.11 | -17.67 | -478.07 | -85.93 | Upgrade
|
| Free Cash Flow | -260.57 | -279.61 | -423.02 | -1,517 | -1,314 | Upgrade
|
| Free Cash Flow Margin | -823.34% | -793.89% | -5063.03% | -1282.16% | - | Upgrade
|
| Free Cash Flow Per Share | -1.57 | -3.09 | -5.14 | -20.14 | -21.06 | Upgrade
|
| Cash Interest Paid | 0 | 0.57 | 0.88 | 0.95 | 1.49 | Upgrade
|
| Cash Income Tax Paid | -0.59 | -1.65 | 0.04 | 12.22 | 7.24 | Upgrade
|
| Levered Free Cash Flow | -166.16 | -191.36 | -289.31 | -1,086 | -699.92 | Upgrade
|
| Unlevered Free Cash Flow | -165.72 | -187.74 | -288.76 | -1,086 | -698.99 | Upgrade
|
| Change in Net Working Capital | -2.47 | 50.16 | 105.73 | 133.43 | -185.83 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.